Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency
Immunosuppressive agents are the standard therapeutic approach for immune thrombocy-topenia (ITP). Their prolonged use may increase the risk of infectious complications, particularly when the patient is already at higher infectious risk. In this setting, the use of drugs with a mechanism of action a...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
PAGEPress Publications
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401131/ |